Skip to main content

Table 1 Comparison of dermatan sulfate (µg/ml) in Amniotic fluid measured by mass spectrometry between nonaffected fetuses, affected fetuses of MPS VI patients and control patients

From: Mass spectrometry and two-dimensional electrophoresis in prenatal diagnosis of mucopolysaccharidosis type VI

Compared items Nonaffected fetuses (5 patients) Affected fetuses (5 patients) Control (20 patients)
Min 20.8 663.8 20.7
Max 61.7 705.6 80.9
Mean 47.8 689.5 54.6
S.D 17.7 16.9 18.2
P 1   0.009
P 2    0.008
P 3 0.753   
  1. P1: comparison between nonaffected and affected fetuses
  2. P2: comparison between affected fetuses and control
  3. P3: comparison between nonaffected fetuses and control